KemPharm (NASDAQ:KMPH) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
KemPharm reported in-line EPS of $-0.05 versus an estimate of $-0.05.
Revenue was down $8.13 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 5.45% drop in the share price the next day.
Here's a look at KemPharm's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.07 | 0.22 | -0.17 |
| EPS Actual | -0.08 | -0.06 | -0.40 | -1.61 |
| Revenue Estimate | 2.23M | 2.18M | 12.10M | 2.10M |
| Revenue Actual | 2.60M | 1.97M | 11.99M | 12.10M |
To track all earnings releases for KemPharm visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
